Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Eph tumour suppression: the dark side of Gleevec.

× No keyword cloud information.

7 in total

Review 1. The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.

Authors: Tressa M Allington; William P Schiemann
Journal: Cells Tissues Organs Date: 2010-11-03 Impact factor: 2.481

2. Cell treatment and lysis in 96-well filter-bottom plates for screening Bcr-Abl activity and inhibition in whole-cell extracts.

Authors: Michael R Mand; Ding Wu; Darren R Veach; Stephen J Kron
Journal: J Biomol Screen Date: 2010-03-17

3. Detection of early Abl kinase activation after ionizing radiation by using a peptide biosensor.

Authors: Jiabin Tang; Jean Y Wang; Laurie L Parker
Journal: Chembiochem Date: 2012-02-14 Impact factor: 3.164

4. Emerging roles for crk in human cancer.

Authors: Ganapathy Sriram; Raymond B Birge
Journal: Genes Cancer Date: 2010-11

5. Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.

Authors: Tressa M Allington; Amy J Galliher-Beckley; William P Schiemann
Journal: FASEB J Date: 2009-08-18 Impact factor: 5.191

Review 6. The multifaceted roles of Eph/ephrin signaling in breast cancer.

Authors: Philip Kaenel; Mischa Mosimann; Anne-Catherine Andres
Journal: Cell Adh Migr Date: 2012-03-01 Impact factor: 3.405

7. c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.

Authors: Chevaun D Morrison; Tressa M Allington; Cheryl L Thompson; Hannah L Gilmore; Jenny C Chang; Ruth A Keri; William P Schiemann
Journal: Oncotarget Date: 2016-11-08

7 in total